BAS/BSCR33 Cardioprotection by hypoxia-inducible factor-1α: underlying beneficial effects on mitochondrial function

Ong, S-G.; Lim, S. Y.; Theodorou, L.; Shukla, D. H.; Maxwell, P. H.; Yellon, D. M.; Hausenloy, D. J.
September 2010
Heart;Sep2010, Vol. 96 Issue 17, pe22
Academic Journal
Introduction Activation of hypoxia-inducible factor-1α (HIF-1α) protects the heart from ischaemia-reperfusion injury, although the underlying mechanisms are unclear. We hypothesised that HIF-1α-induced cardioprotection is mediated by beneficial effects on mitochondrial function. Methods and results Two different experimental models of HIF-1α activation were used: (1) pharmacological inhibition of proline hydroxylase (PHD) and (2) genetic inactivation of von Hippel-Lindau (VHL), proteins responsible for HIF-1α degradation under normoxic conditions. A single dose (3-mg/kg) of the PHD inhibitor (GSK0360A or PHDi), administered by oral gavage 4-h before ex vivo myocardial infarction, reduced myocardial infarct size (percentage of the area at risk) in male Sprague-Dawley rats (30.6%±2.9% PHDi vs 44.2%±2.9%; p<0.5; N>5). Next, conditional cardiac-specific VHL knockout mice (VHL-KO) that express an inducible Cre-recombinase transgene to delete the VHL-floxed gene within the heart following tamoxifen induction, expressed higher levels of HIF-1 in the heart as assessed by immunostaining. The activation of myocardial HIF-1 resulted in a smaller myocardial infarct size in comparison with the littermate control (29.1%±4.7% in VHL-KO vs 52.5%±3.3% in control; p<0.05; N>5/group). In VHL-KO cardiomyocytes subjected to simulated ischaemia-reperfusion injury (SIRI) (120-min ischaemia and 15-min reperfusion, the production of reactive oxygen species (ROS) (measured by reduced Mitotracker Red fluorescence)(1.0%±0.1-fold increase in VHL-KO vs 1.3%±0.2-fold increase in control; p<0.05; N>3 experiments each with 40 cells) and mitochondrial permeability transition pore (mPTP) opening sensitivity was reduced (measured by TMRM fluorescence) (1.1%±0.1 fold increase in VHL-KO vs 1.4%±0.1 fold increase in control; p<0.05; N>3 experiments each with 40 cells). Conclusions HIF-1α activation by genetic deletion of VHL or pharmacological inhibition of PHD, is cardioprotective and this protective effect can be attributed in part to beneficial effects on the mitochondria.


Related Articles

  • Pharmacological Pre- and Post- Conditioning Agents: Reperfusion-Injury of the Heart Revisited. Andreadou, Ionna; Iliodromitis, Efstathios K.; Koufaki, Maria; Kremastinos, Dimitrios Th. // Mini Reviews in Medicinal Chemistry;Aug2008, Vol. 8 Issue 9, p952 

    Ischemic preconditioning (PC) and postconditioning (PostC) are endogenous mechanisms of protection of the ischemic heart. In brief, short cycles of sublethal ischemia separated by brief periods of reperfusion render the heart resistant to infarction from a subsequent lethal episode of prolonged...

  • Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Romanic, Anne M.; Harrison, Stephen M.; Bao, Weike; Burns-Kurtis, Cynthia L.; Pickering, Susan; Gu, Juanli; Grau, Evelyn; Mao, Joyce; Sathe, Ganesh M.; Ohlstein, Eliot H.; Yue, Tian-Li // Cardiovascular Research;Jun2002, Vol. 54 Issue 3, p549 

    Objective: Matrix metalloproteinase-9 (MMP-9) activity is up regulated in the heart subjected to ischemic insult. Whether increased MMP-9 activity contributes to acute myocardial injury after ischemia�reperfusion remains unknown. To investigate the role of MMP-9 in myocardial...

  • Role of large-conductance Ca2+-activated K+ channels in adenosine A1 receptor-mediated pharmacological postconditioning in H9c2 cells. Fretwell, Laurice; Dickenson, John M. // Canadian Journal of Physiology & Pharmacology;Jan2011, Vol. 89 Issue 1, p24 

    Ischaemic postconditioning is a phenomenon whereby short periods of ischaemia applied during the start of reperfusion protect the myocardium from the damaging consequences of reperfusion. As such, pharmacological-induced postconditioning represents an attractive therapeutic strategy for reducing...

  • Limited effects of post-ischemic NHE blockade on [Na+]i and pHi in rat hearts explain its lack of cardioprotection Ten Hove, Michiel; Van Echteld, Cees J.A. // Cardiovascular Research;Feb2004, Vol. 61 Issue 3, p522 

    Objective: Na+/H+ exchanger (NHE) blockade fails as reperfusion therapy in patients with acute myocardial infarction. In experimental studies, the reports on the efficacy of NHE blockade only during reperfusion are inconsistent. Differences in the severity of ischemia and in drug delivery may...

  • Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia–reperfusion injury in a preclinical pig model Kupatt, Christian; Hinkel, Rabea; Horstkotte, Jan; Deiß, Michael; von Brühl, Marie-Luise; Bilzer, Manfred; Boekstegers, Peter // Cardiovascular Research;Feb2004, Vol. 61 Issue 3, p530 

    Objective: Reperfusion after ischemia may contribute to loss of myocardial function and increase in infarct size. Scavenging of reactive oxygen species (ROS) by glutathione (GSH) and inhibition of the sodium-proton-exchanger by cariporide are both capable of reducing myocardial reperfusion...

  • Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury Bao, Weike; Hu, Erding; Tao, Ling; Boyce, Rogely; Mirabile, Rosanna; Thudium, Douglas T.; Ma, Xin-ling; Willette, Robert N.; Yue, Tian-li // Cardiovascular Research;Feb2004, Vol. 61 Issue 3, p548 

    Objective: To investigate the role of Rho A and Rho-kinase in acute myocardial ischemia/reperfusion injury and the protective effect of Rho-kinase inhibitor, Y-27632 [(R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide]. Methods and results: Male CD1 mice were subjected to 30 min...

  • Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats. Zhu, Jianhua; Qiu, Yuangang; Wang, Qiqi; Zhu, Yujuan; Hu, Shenjiang; Zheng, Liangrong; Wang, Lihong; Zhang, Yun // European Journal of Cardio-Thoracic Surgery;Sep2008, Vol. 34 Issue 3, p661 

    Abstract: Objectives: The effect of low dose of cyclophosphamide (CP) protecting cardiac function from ischemia-reperfusion injury was studied on rats. The premise is that CP inhibits immune and inflammatory process, thereby limits I/R injury and improves myocardial function. Methods: Open chest...

  • Urotensin-â…¡Receptor Antagonist SB-710411 Protects Rat Heart against Ischemia-Reperfusion Injury via RhoA/ROCK Pathway. Luo, Sheng-Yong; Chen, Shuo; Qin, Yi-De; Chen, Zhi-Wu // PLoS ONE;1/15/2016, Vol. 11 Issue 1, p1 

    Aim: SB-710411 is a rat selective urotensin-II (U-II) receptor antagonist, which can block U-II-induced contraction of the aorta and inhibit U-II-induced myocardial fibrosis in rats. However, the effect of SB-710411 on myocardial ischemia-reperfusion (I/R) injury is unclear. The present study...

  • Perconditioning and Postconditioning: Current Knowledge, Knowledge Gaps, Barriers to Adoption, and Future Directions. Vinten-Johansen, Jakob; Shi, Weiwei // Journal of Cardiovascular Pharmacology & Therapeutics;Sep2011, Vol. 16 Issue 3/4, p260 

    The broad definition of “conditioning” is the application of a series of alternating intervals of brief ischemia (hypoxia) and reperfusion (reoxygenation) applied in the setting of prolonged ischemia causing myocardial infarction. While the conditioning stimulus is applied before the...


Read the Article


Sign out of this library

Other Topics